News brief
On 2026-02-11, according to Xiniu Data, Zhiran Medical completed Series A+ financing, raising RMB 300 million. Investors were Yuansheng Venture Capital, Junlian Capital, Hongshan China, Xingze Capital and others.
Connected profiles
Explore
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
2026年2月11日，据烯牛数据报道，智冉医疗完成A+轮融资，金额3亿人民币。投资方为元生创投、君联资本、红杉中国、杏泽资本等。